Biora Therapeutics to Announce Q2 2024 Financial Results and Corporate Update

SAN DIEGO, August 8, 2024 - Biora Therapeutics, Inc., a clinical-stage biotech firm listed on Nasdaq under the ticker symbol BIOR, announced its plans to release its financial results and provide a corporate update for the second quarter ending June 30, 2024. The company's management team will host a webcast and conference call on Monday, August 12, 2024, following the closure of financial markets.

The conference call is scheduled for 4:30 PM Eastern Time, or 1:30 PM Pacific Time. Domestic participants can dial in at 1-877-423-9813, while international participants can join by calling 1-201-689-8573. The conference ID for the call is 13747616. There will also be an option for instant telephone access by following the provided link. Additionally, a live webcast of the call will be available on Biora Therapeutics' investor relations website. A replay of the webcast will be accessible on the company's website for a duration of 60 days.

Biora Therapeutics is advancing in the biotech field with two primary smart pill-based platforms. The first is the NaviCap™ platform, aimed at colon-targeted treatment of Inflammatory Bowel Disease (IBD). This platform is designed to enhance patient outcomes by delivering treatments directly to the site of the disease within the gastrointestinal tract. The second is the BioJet™ platform, which focuses on the oral delivery of large molecules, potentially replacing the need for injections with a needle-free delivery system. This innovation is intended to improve the management of chronic diseases.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!